PRKN and Parkinson disease: Indeed, we observed a significant four-fold increase of immature forms in PARK2-PD cells compared to CTR1 and CTR2 controls, indicating that the pathway of Cathepsin D maturation is impaired in PARK2-PD cells (Figure 2D).